Business Description
TaiwanJ Pharmaceuticals Co Ltd
ISIN : TW0006549009
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 50.24 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.67 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 70.09 | |||||
Beneish M-Score | -5.52 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 65.9 | |||||
3-Year EPS without NRI Growth Rate | 48.9 | |||||
3-Year FCF Growth Rate | 63.2 | |||||
3-Year Book Growth Rate | -27.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.63 | |||||
9-Day RSI | 26.44 | |||||
14-Day RSI | 31.26 | |||||
6-1 Month Momentum % | 0.78 | |||||
12-1 Month Momentum % | -53.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.43 | |||||
Quick Ratio | 10.43 | |||||
Cash Ratio | 9.57 | |||||
Days Sales Outstanding | 73.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.04 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -29.07 | |||||
Net Margin % | -26.59 | |||||
FCF Margin % | -9.95 | |||||
ROE % | -8.14 | |||||
ROA % | -7.49 | |||||
ROIC % | -92.05 | |||||
ROC (Joel Greenblatt) % | -72.28 | |||||
ROCE % | -4.99 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 39.46 | |||||
PB Ratio | 13.24 | |||||
Price-to-Tangible-Book | 13.26 | |||||
EV-to-EBIT | -221.07 | |||||
EV-to-EBITDA | -477.14 | |||||
EV-to-Revenue | 36.44 | |||||
EV-to-FCF | -374.7 | |||||
Price-to-Net-Current-Asset-Value | 15.53 | |||||
Price-to-Net-Cash | 16.86 | |||||
Earnings Yield (Greenblatt) % | -0.45 | |||||
FCF Yield % | -0.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TaiwanJ Pharmaceuticals Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 22.742 | ||
EPS (TTM) (NT$) | -0.08 | ||
Beta | 0.16 | ||
Volatility % | 39.39 | ||
14-Day RSI | 31.26 | ||
14-Day ATR (NT$) | 0.568507 | ||
20-Day SMA (NT$) | 12.4025 | ||
12-1 Month Momentum % | -53.69 | ||
52-Week Range (NT$) | 11.45 - 30 | ||
Shares Outstanding (Mil) | 75.12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TaiwanJ Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TaiwanJ Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
TaiwanJ Pharmaceuticals Co Ltd Frequently Asked Questions
What is TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549)'s stock price today?
When is next earnings date of TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549)?
Does TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |